PMID: 9417511Jan 1, 1997Paper

High-dose therapy with fluconazole > or = 800 mg/day. Review

Mycoses
A Penk, L Pittrow

Abstract

The clinical use of fluconazole in dosages > or = 800 mg/day has been reported in about 900 patients against candidemia, oropharyngeal candidiasis and cryptococcal meningitis in HIV-infected patients as well as for initial therapy of endemic mycoses. Especially in patients with life-threatening infections caused by Candida spp., Cryptococcus neoformans and Coccidioides immitis, the results of a limited number of dose-finding trials with non-neutropenic and HIV-infected patients show dose-dependent response rates. These findings strongly advocate the application of high dose-fluconazole; their evaluation, however, still awaits final clarification. The good safety profile for dosages up to 2000 mg/day and the linear, predictable pharmacokinetics up to 1600 mg/day indicate the excellent tolerability of fluconazole in the clinical situation which justifies prospective, randomized clinical trials with treatment groups as homogeneous as possible for further evaluation of the optimum dosage and duration of treatment.

References

Feb 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G BodeyS Milliken
Apr 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Pfaller, R Wenzel
May 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D Milatovic, A Voss
Sep 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V J FraserW C Dunagan
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W G Powderly
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M DiazE G Arathoon
Apr 1, 1992·The Journal of Antimicrobial Chemotherapy·W R Jarvis, W J Martone
Mar 1, 1992·Antimicrobial Agents and Chemotherapy·A J BerryJ R Graybill
Feb 1, 1991·Antimicrobial Agents and Chemotherapy·C ViscoliA Terragna
Apr 1, 1990·The Journal of Antimicrobial Chemotherapy·A M AnsariJ G Douglas
Oct 1, 1989·Archives of Internal Medicine·S B WeyR P Wenzel
Dec 1, 1988·Archives of Internal Medicine·S B WeyR P Wenzel
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R P Wenzel
Aug 1, 1995·The Journal of Infectious Diseases·E J AnaissieG P Bodey
Sep 1, 1995·Annals of Internal Medicine·P G PappasJ D Sobel
Jan 1, 1995·Clinical Microbiology Reviews·J Wheat
Jul 1, 1994·Mycoses·T ReblinH Greten
Oct 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A LarsenJ M Leedom
Jun 1, 1994·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·R D Meyer
Nov 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A PaugamD Sicard
Nov 1, 1994·Mayo Clinic Proceedings·G A Sarosi, S F Davies
Apr 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C FasanoD Gibbs
Apr 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E Presterl, W Graninger
Apr 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C FasanoD Gibbs
Feb 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S ReddingM Pfaller
Apr 15, 1993·Annals of Internal Medicine·J WheatUNKNOWN National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators
Mar 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H E Einstein, R H Johnson
Mar 1, 1993·The Journal of Infection·W GraningerA Georgopoulos
Jul 1, 1993·Annals of Internal Medicine·J N GalgianiJ R Graybill
Jul 1, 1995·Mycoses·B KoszycaR W Byard
Nov 1, 1995·The Journal of Antimicrobial Chemotherapy·E M Johnson, D W Warnock
Oct 1, 1995·Clinical Microbiology Reviews·T G Mitchell, J R Perfect
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A Kauffman
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F MenichettiS Pauluzzi
Aug 31, 1996·Lancet·S SundarH W Murray
May 1, 1996·The Journal of Antimicrobial Chemotherapy·S Hood, D W Denning

❮ Previous
Next ❯

Citations

Jun 24, 2009·Current Infectious Disease Reports·Janis E Blair
Apr 12, 2002·Lancet·Dimitrios P Kontoyiannis, Russell E Lewis
Dec 4, 2003·The Lancet Infectious Diseases·Philippe EggimannDidier Pittet
Jun 26, 1999·Clinical Transplantation·A MesaG Durango
Nov 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicky LongleyThomas S Harrison
Dec 10, 1999·The Journal of Antimicrobial Chemotherapy·M V Martin
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Robert A LarsenJ Richard Graybill
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Cornelius J ClancyM Hong Nguyen
May 3, 2002·Drugs·Maher M BalkisMahmoud A Ghannoum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M S SaagW E Dismukes
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
© 2021 Meta ULC. All rights reserved